Interim results from a National Institutes of Health (NIH)-supported clinical trial of the Bavarian Nordic mpox vaccine ...

Today, The Lancet published the first real-world data analysis of respiratory syncytial virus (RSV) vaccine efficacy among ...

Time to sustained recovery, defined as 3 or more days without symptoms, didn't differ between the 628 and 622 participants ...

Routine childhood vaccine uptake among US kindergarteners in public and private schools declined to less than 93% in the 2023 ...

Dairy workers in California continue to face a daunting threat from a virus surge in the state’s dairy cows, as federal ...

Over the past week, Africa’s surge of new mpox cases continued, and the region passed a grim marker, with fatal cases passing ...

Patients considered highly socially vulnerable were significantly more likely to be diagnosed with severe Clostridioides ...

The disease continues to spread in the Americas, with Ecuador and Guyana recently reporting their first cases.

Data collected at the University Hospitals of Cleveland show that overall US vaccination rates for influenza, SARS-CoV-2, and ...

Matshidiso Moeti, MBBS, head of the WHO Africa regional office, said on X today that the clinical trial will test the ...

An observational study of 614,000 US patients suggests a higher risk of new-onset type 2 diabetes (T2D) after COVID-19 than ...

In related developments, the WHO weighed in on the latest epi data and recent travel-related measures from other countries.